
    
      Sleeping condition and severity of restless legs syndrome (RLS) were recorded at the start
      and during the treatment. The treatment period is scheduled to last 52 weeks in principle.
      For patients completing or discontinuing the use of RegniteÂ® within 52 weeks, follow up on
      the withdrawal and rebound syndrome will be conducted up to 4 weeks of completion or
      discontinuation.
    
  